Checkpoint Therapeutics (CKPT) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free CKPT Stock Alerts $1.79 -0.05 (-2.72%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Checkpoint Therapeutics Short Interest DataCurrent Short Interest3,970,000 sharesPrevious Short Interest3,520,000 sharesChange Vs. Previous Month+12.78%Dollar Volume Sold Short$6.47 millionShort Interest Ratio9.8 Days to CoverLast Record DateMay 15, 2024Outstanding Shares35,690,000 sharesFloat Size31,310,000 sharesShort Percent of Float12.68%Today's Trading Volume290,643 sharesAverage Trading Volume513,375 sharesToday's Volume Vs. Average57% Short Selling Checkpoint Therapeutics ? Sign up to receive the latest short interest report for Checkpoint Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCKPT Short Interest Over TimeCKPT Days to Cover Over TimeCKPT Percentage of Float Shorted Over Time Ad Stansberry ResearchA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here. Checkpoint Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20243,970,000 shares $6.47 million +12.8%12.7%9.8 $1.63 4/30/20243,520,000 shares $4.89 million -6.9%11.5%8.9 $1.39 4/15/20243,780,000 shares $6.50 million +1.1%12.4%7.9 $1.72 3/31/20243,740,000 shares $7.67 million +1.9%12.2%6.9 $2.05 3/15/20243,670,000 shares $7.05 million +9.6%18.2%5.6 $1.92 2/29/20243,350,000 shares $7.00 million -2.9%16.6%3.7 $2.09 Get the Latest News and Ratings for CKPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,450,000 shares $6.93 million +0.6%17.1%3.7 $2.01 1/31/20243,430,000 shares $7.00 million -9.0%17.0%3.8 $2.04 1/15/20243,770,000 shares $7.31 million -7.4%18.7%4.6 $1.94 12/31/20234,070,000 shares $9.32 million +0.3%20.2%5.5 $2.29 12/15/20234,060,000 shares $13.48 million +28.1%19.9%6.1 $3.32 11/30/20233,170,000 shares $8.43 million +19.6%15.7%8.2 $2.66 11/15/20232,650,000 shares $4.98 million +10.9%13.1%10 $1.88 10/31/20232,390,000 shares $4.45 million +10.7%12.9%8.8 $1.86 10/15/20232,160,000 shares $4.04 million +19.3%11.7%7.2 $1.87 9/30/20231,810,000 shares $3.08 million +17.5%9.8%6.2 $1.70 9/15/20231,540,000 shares $3.03 million -2.5%8.6%5.9 $1.97 8/31/20231,580,000 shares $3.18 million +1.3%9.5%6.2 $2.01 8/15/20231,560,000 shares $3.15 million +6.1%9.4%5.8 $2.02 7/31/20231,470,000 shares $3.81 million +3.5%10.6%6 $2.59 7/15/20231,420,000 shares $3.82 million +3.7%11.9%6.9 $2.69 6/30/20231,370,000 shares $3.38 million +18.1%11.5%6.3 $2.47 6/15/20231,160,000 shares $3.20 million +11.5%9.1%3.7 $2.76 5/31/20231,040,000 shares $2.75 million +54.6%8.3%3.4 $2.64 5/15/2023672,900 shares $1.90 million +22.8%5.4%2.2 $2.83 4/30/2023548,200 shares $1.81 million +7.2%4.8%1.9 $3.30 4/15/2023511,300 shares $1.33 million -9.5%5.0%1.8 $2.61 3/31/2023564,900 shares $1.27 million +30.1%5.5%2 $2.25 3/15/2023434,200 shares $1.66 million +6.0%6.4%2.1 $3.82 2/28/2023409,500 shares $1.91 million +42.4%6.1%2.1 $4.67 2/15/2023287,600 shares $1.48 million +4.1%4.3%1.7 $5.14 1/31/2023276,300 shares $1.38 million -3.9%4.1%1.8 $4.98 1/15/2023287,500 shares $2.19 million -13.3%4.3%2.2 $7.60 12/30/2022331,700 shares $1.69 million -39.9%4.6%3.5 $5.11 12/15/2022552,200 shares $2.21 million +74.0%7.7%10.7 $4.00 11/30/2022317,400 shares $187,234.26 -90.1%N/A7.8 $0.59 11/15/20223,220,000 shares $2.43 million +4.2%4.5%11.5 $0.76 10/31/20223,090,000 shares $3.09 million -1.3%4.3%10.8 $1.00 10/15/20223,130,000 shares $3.12 million -2.2%4.4%10.5 $1.00 9/30/20223,200,000 shares $3.33 million +1.0%N/A10 $1.04Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 9/15/20223,170,000 shares $4.03 million -3.4%N/A9.5 $1.27 8/31/20223,280,000 shares $4.23 million -0.3%N/A8.5 $1.29 8/15/20223,290,000 shares $4.84 million -8.4%N/A7.7 $1.47 7/31/20223,590,000 shares $4.02 million +14.7%N/A7.3 $1.12 7/15/20223,130,000 shares $3.41 million +1.0%N/A6.4 $1.09 6/30/20223,100,000 shares $3.19 million -4.6%N/A5.4 $1.03 6/15/20223,250,000 shares $3.51 million -4.1%N/A5.3 $1.08 5/31/20223,390,000 shares $4.81 million -1.7%N/A4.8 $1.42 5/15/20223,450,000 shares $4.42 million +0.6%N/A4 $1.28 4/30/20223,430,000 shares $4.32 million +3.0%4.9%3.8 $1.26 4/15/20223,330,000 shares $4.80 million -29.5%4.8%2.2 $1.44 3/31/20224,720,000 shares $8.35 million -4.8%6.8%3 $1.77 3/15/20224,960,000 shares $8.38 million +37.0%7.7%3.3 $1.69 2/28/20223,620,000 shares $6.48 million +6.2%5.6%2.4 $1.79 2/15/20223,410,000 shares $7.40 million -21.6%5.3%2.3 $2.17 1/31/20224,350,000 shares $11.01 million +19.8%6.8%2.9 $2.53 1/15/20223,630,000 shares $9.47 million +22.6%N/A2.5 $2.61 12/31/20212,960,000 shares $9.21 million +11.3%4.6%3.3 $3.11 12/15/20212,660,000 shares $7.71 million +4.7%4.1%3.1 $2.90 11/30/20212,540,000 shares $7.52 million +25.1%3.9%3 $2.96 11/15/20212,030,000 shares $8.02 million +18.7%3.1%2.5 $3.95 10/29/20211,710,000 shares $6.00 million -1.2%2.7%2.4 $3.51 10/15/20211,730,000 shares $5.74 million No Change2.7%2.9 $3.32 9/30/20211,730,000 shares $5.71 million -3.4%2.7%2.5 $3.30 9/15/20211,790,000 shares $5.67 million -25.7%2.8%2.1 $3.17 8/31/20212,410,000 shares $7.76 million +0.8%3.8%2.4 $3.22 8/13/20212,390,000 shares $6.52 million -4.8%3.8%1.8 $2.73 7/30/20212,510,000 shares $6.60 million +4.6%4.0%1.8 $2.63 7/15/20212,400,000 shares $6.65 million +20.6%4.0%1.6 $2.77 6/30/20211,990,000 shares $5.87 million -58.8%3.3%1.4 $2.95 6/15/20214,830,000 shares $13.62 million +45.1%8.0%3.7 $2.82 5/28/20213,330,000 shares $8.92 million +9.5%5.5%2.7 $2.68 5/14/20213,040,000 shares $7.24 million +3.1%N/A3 $2.38 4/30/20212,950,000 shares $8.73 million +8.5%N/A2.1 $2.96 4/15/20212,720,000 shares $7.97 million +12.9%N/A2 $2.93 3/31/20212,410,000 shares $7.37 million -7.0%N/A1.7 $3.06 3/15/20212,590,000 shares $9.07 million +19.4%N/A1.8 $3.50 2/26/20212,170,000 shares $7.10 million -8.4%N/A1.6 $3.27 2/12/20212,370,000 shares $9.86 million -3.3%N/A1.9 $4.16 1/29/20212,450,000 shares $7.94 million -8.2%N/A3.1 $3.24 1/15/20212,670,000 shares $9.00 million +30.2%N/A3.8 $3.37 12/31/20202,050,000 shares $5.49 million -3.3%N/A3.6 $2.68 12/15/20202,120,000 shares $5.24 million -0.5%N/A3.4 $2.47 11/30/20202,130,000 shares $5.05 million -3.6%N/A2.1 $2.37 11/15/20202,210,000 shares $5.50 million -7.9%N/A2.2 $2.49 10/30/20202,400,000 shares $5.66 million +8.1%N/A2.4 $2.36 10/15/20202,220,000 shares $5.88 million -5.1%N/A2.1 $2.65 9/30/20202,340,000 shares $6.27 million +5.4%N/A1.7 $2.68 9/15/20202,220,000 shares $8.68 million +25.4%N/A1.8 $3.91 8/31/20201,770,000 shares $3.86 million +18.8%N/A2.6 $2.18Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 8/14/20201,490,000 shares $3.07 million +31.9%N/A2.3 $2.06 7/31/20201,130,000 shares $2.54 million +26.9%N/A1.8 $2.25 7/15/2020890,200 shares $1.50 million -0.7%N/A1.4 $1.68 6/30/2020896,300 shares $1.79 million +33.6%N/A3.1 $2.00 6/15/2020670,700 shares $1.31 million -7.7%N/A2.6 $1.96 5/29/2020726,700 shares $1.61 million -10.9%N/A2.7 $2.21 5/15/2020815,800 shares $1.44 million -13.9%N/A3 $1.76 4/30/2020947,000 shares $1.67 million +68.3%N/A3.5 $1.76 4/15/2020562,600 shares $821,396.00 -13.4%N/A2.7 $1.46 3/31/2020649,500 shares $1.00 million -11.7%N/A2.7 $1.54 3/13/2020735,700 shares $1.02 million +5.7%N/A4.6 $1.38 2/28/2020695,800 shares $828,002.00 +3.8%N/A2.7 $1.19 2/14/2020670,300 shares $1.08 million +16.8%N/A2.3 $1.61 1/31/2020573,900 shares $1.27 million +14.1%N/A2.1 $2.21 1/15/2020502,900 shares $1.03 million -12.8%N/A2 $2.05 12/31/2019576,700 shares $1.09 million +4.4%2.3%2.5 $1.89 8/15/2019541,000 shares $1.54 million -7.6%2.7%4.2 $2.85 CKPT Short Interest - Frequently Asked Questions What is Checkpoint Therapeutics' current short interest? Short interest is the volume of Checkpoint Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 3,970,000 shares of CKPT short. 12.68% of Checkpoint Therapeutics' shares are currently sold short. Learn More on Checkpoint Therapeutics' current short interest. What is a good short interest ratio for Checkpoint Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CKPT shares currently have a short interest ratio of 10.0. Learn More on Checkpoint Therapeutics's short interest ratio. Which institutional investors are shorting Checkpoint Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Checkpoint Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Checkpoint Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.68% of Checkpoint Therapeutics' floating shares are currently sold short. Is Checkpoint Therapeutics' short interest increasing or decreasing? Checkpoint Therapeutics saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 3,970,000 shares, an increase of 12.8% from the previous total of 3,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Checkpoint Therapeutics' float size? Checkpoint Therapeutics currently has issued a total of 35,690,000 shares. Some of Checkpoint Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Checkpoint Therapeutics currently has a public float of 31,310,000 shares. How does Checkpoint Therapeutics' short interest compare to its competitors? 12.68% of Checkpoint Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Checkpoint Therapeutics: Landos Biopharma, Inc. (0.05%), Marinus Pharmaceuticals, Inc. (8.90%), MediciNova, Inc. (0.34%), Lantern Pharma Inc. (5.50%), Tempest Therapeutics, Inc. (9.61%), LAVA Therapeutics (0.84%), Journey Medical Co. (2.94%), Rallybio Co. (8.08%), BioXcel Therapeutics, Inc. (4.34%), Eledon Pharmaceuticals, Inc. (0.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Checkpoint Therapeutics stock? Short selling CKPT is an investing strategy that aims to generate trading profit from Checkpoint Therapeutics as its price is falling. CKPT shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Checkpoint Therapeutics? A short squeeze for Checkpoint Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CKPT, which in turn drives the price of the stock up even further. How often is Checkpoint Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CKPT, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LPTX Short Interest ENTA Short Interest XBIT Short Interest IMMP Short Interest EBS Short Interest ME Short Interest DSGN Short Interest ACRV Short Interest FHTX Short Interest ALDX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CKPT) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
